Novo Nordisk stock rises as drugmaker drops out of bidding war for Metsera

Published 1 hour ago Negative
Novo Nordisk stock rises as drugmaker drops out of bidding war for Metsera
[Scientist analyzing medical sample in laboratory]
Morsa Images

* Novo Nordisk (NVO [https://seekingalpha.com/symbol/NVO]) rose nearly 4% in premarket trading on Monday, after the Danish biotech said it will no longer increase its buyout offer for Metsera (MTSR [https://seekingalpha.com/symbol/MTSR]).
* The announcement [https://seekingalpha.com/news/4519038-novo-nordisk-ends-metsera-fight-pfizer-inks-10b-dea]came after Pfizer (PFE [https://seekingalpha.com/symbol/PFE]) won a bitter bidding war for the U.S. weight-loss drug developer, reaching a deal worth up to $10B.
* Late Friday, New York-based Metsera (MTSR [https://seekingalpha.com/symbol/MTSR]) announced that it reached a revised merger agreement with Pfizer (PFE [https://seekingalpha.com/symbol/PFE]) to be acquired by the pharma giant for up to $86.25 per share in cash, which it has deemed superior given the evolving antitrust risks of Novo’s (NVO [https://seekingalpha.com/symbol/NVO]) bid.
* Shares of Novo Nordisk (NVO [https://seekingalpha.com/symbol/NVO]) which, trimmed [https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916445]its forecast for a fourth time this year last week, citing lower-than-expected sales of its blockbuster drugs Wegovy and Ozempic, are down 47% so far this year.

MORE ON NOVO NORDISK

* Novo Nordisk: Hold On Tightly As The Market Tests Your Faith [https://seekingalpha.com/article/4841020-novo-nordisk-hold-on-tightly-as-market-tests-your-faith]
* Eli Lilly, Novo Nordisk's Historic GLP-1 Pricing Deals - What Investors Need To Know [https://seekingalpha.com/article/4840321-eli-lilly-novo-nordisk-historic-glp-1-pricing-deals-what-investors-need-to-know]
* Novo Nordisk A/S (NVO) Q3 2025 Earnings Call Transcript [https://seekingalpha.com/article/4838202-novo-nordisk-a-s-nvo-q3-2025-earnings-call-transcript]
* Key deals this week: ITV-Sky, Metsera, Kyndryl, SM Energy, KNOT Offshore, Sonida Senior and more [https://seekingalpha.com/news/4519030-key-deals-this-week-itv-sky-metsera-kyndryl-sm-energy-knot-offshore-sonida-senior-and-more]
* Novo Nordisk gives up battle for Metsera as Pfizer inks $10B deal [https://seekingalpha.com/news/4519038-novo-nordisk-ends-metsera-fight-pfizer-inks-10b-dea]